Patents Assigned to Trojan Technologies Limited
  • Patent number: 8735340
    Abstract: The subject invention pertains to a conjugate comprising: (a) a first region comprising the homeodomain of antennapedia or a variant thereof; and (b) a second region not naturally associated with the first region. In one embodiment, the second region of the conjugate comprises a protein of at least 100 amino acids.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: May 27, 2014
    Assignee: Trojan Technologies Limited
    Inventor: Andrea Crisanti
  • Patent number: 7968512
    Abstract: The subject invention pertains to a conjugate comprising: (a) a first region comprising the homeodomain of antennapedia or a variant thereof; and (b) a second region not naturally associated with the first region. In one embodiment, the second region of the conjugate comprises a protein of at least 100 amino acids.
    Type: Grant
    Filed: February 27, 2004
    Date of Patent: June 28, 2011
    Assignee: Trojan Technologies Limited
    Inventor: Andrea Crisanti
  • Publication number: 20110021441
    Abstract: The P21 protein is used as a medicament in the treatment of cancer. A conjugate comprises a first region comprising the P21 protein, or a homologue or functional fragment thereof; and a second region comprising a translocation factor.
    Type: Application
    Filed: October 29, 2009
    Publication date: January 27, 2011
    Applicant: Trojan Technologies Limited
    Inventors: Agamemnon Epenetos, Christina Kousparou
  • Publication number: 20080287357
    Abstract: The P21 protein is used as a medicament in the treatment of cancer. A conjugate comprises a first region comprising the P21 protein, or a homologue or functional fragment thereof; and a second region comprising a translocation factor.
    Type: Application
    Filed: April 18, 2006
    Publication date: November 20, 2008
    Applicant: Trojan Technologies Limited
    Inventors: Agamemnon Epenetos, Christina Kousparou